Story

Nvidia, Eli Lilly Among Six Stocks Meeting Long-Term Growth Criteria, Analysis Shows

ENTHMSVIIDZHZH-TWJAKOHI
Jul 31, 20262 min read
Nvidia, Eli Lilly Among Six Stocks Meeting Long-Term Growth Criteria, Analysis Shows
Text size
Background

An analysis applying specific financial criteria to the U.S. market has highlighted six companies with metrics consistent with long-term compounders, spanning the technology, pharmaceutical, and cybersecurity sectors. The list, which includes Nvidia (NVDA), Eli Lilly (LLY), and Meta Platforms (META), was derived from a screen focused on sustained growth and high returns on capital.

The Selection Criteria

According to an analysis published by Investing.com, the initial screen filtered for companies demonstrating strong historical performance and financial stability. The core requirements included:

  • A 5-year revenue compound annual growth rate (CAGR) above 8%
  • A return on equity (ROE) greater than 15%
  • A financial health score above 2.5 (on the platform's scale)
  • A 5-year price return of more than 50%

This process reportedly narrowed the U.S. market down to 68 companies, from which the final six were selected based on factors like return on invested capital (ROIC) and forward valuation.

Tech and Pharma Dominate List

Sample IUX Markets – In-articleAd

The six companies identified are heavily concentrated in sectors benefiting from secular growth trends like artificial intelligence, cloud infrastructure, and new pharmaceutical developments. Key metrics cited in the analysis include:

  • NVIDIA (NVDA): Noted for its 66.9% 5-year revenue CAGR and 95.5% ROIC, driven by its central role in the AI computing buildout.
  • Broadcom (AVGO): Highlighted for its 21.7% revenue CAGR and a strong position in custom AI chips and networking infrastructure, with a gross margin of 76.3%.
  • Meta Platforms (META): Recognized for its 18.5% revenue CAGR and a forward P/E ratio of 17.1x, considered low relative to its 81.7% gross margin and market dominance.
  • Eli Lilly (LLY): Selected for its 21.6% revenue CAGR and 45.0% ROIC, largely based on the significant market potential of its GLP-1 drug pipeline.
  • Arista Networks (ANET): Included for its 31.2% revenue CAGR and its role in providing essential networking infrastructure for AI data centers.
  • Fortinet (FTNT): Featured for its 21.3% revenue CAGR, capitalizing on the persistent demand for cybersecurity solutions.

Market Implications

The selection underscores a focus on companies with established market leadership and durable business models capable of generating high returns through economic cycles. For investors, the list points toward themes of AI infrastructure, digital advertising, and biopharmaceutical innovation as primary drivers of long-term value creation.

However, the analysis also notes that several of these companies, such as Arista Networks and Fortinet, trade at high forward price-to-earnings multiples (46.6x and 54.1x, respectively). This reflects the market's high expectations for their continued growth, which also presents a risk if that growth decelerates.

Read next

More on Stocks
Back to latest news

LATEST